Prosecution Insights
Last updated: April 19, 2026

St Phi Therapeutics Co. Ltd.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18731402 Chimeric Natural Killer Cell Receptors and Method of Using Thereof KAUFMAN, CLAIRE M 1674 Non-Final OA Jun 03, 2024
18263860 TARGETED PROTEIN DEGRADATION SYSTEM AND USE THEREOF AEDER, SEAN E 1642 Non-Final OA Aug 01, 2023

Managing St Phi Therapeutics Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month